Logo image of WEST

WESTROCK COFFEE CO (WEST) Stock Fundamental Analysis

NASDAQ:WEST - US96145W1036 - Common Stock

5.26 USD
-0.16 (-2.95%)
Last: 9/5/2025, 8:00:02 PM
5.15 USD
-0.11 (-2.09%)
After Hours: 9/5/2025, 8:00:02 PM
Fundamental Rating

1

WEST gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 88 industry peers in the Food Products industry. Both the profitability and financial health of WEST have multiple concerns. WEST does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year WEST has reported negative net income.
WEST had a negative operating cash flow in the past year.
WEST had negative earnings in 4 of the past 5 years.
WEST had a negative operating cash flow in each of the past 5 years.
WEST Yearly Net Income VS EBIT VS OCF VS FCFWEST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of WEST (-4.07%) is worse than 66.29% of its industry peers.
WEST has a Return On Equity of -10.18%. This is in the lower half of the industry: WEST underperforms 68.54% of its industry peers.
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROIC N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WEST Yearly ROA, ROE, ROICWEST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -50 -100

1.3 Margins

WEST has a Gross Margin of 16.27%. This is comparable to the rest of the industry: WEST outperforms 43.82% of its industry peers.
WEST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEST Yearly Profit, Operating, Gross MarginsWEST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 -5 10 15

More info and screens

1

2. Health

2.1 Basic Checks

WEST does not have a ROIC to compare to the WACC, probably because it is not profitable.
WEST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WEST Yearly Shares OutstandingWEST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
WEST Yearly Total Debt VS Total AssetsWEST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

WEST has an Altman-Z score of 1.17. This is a bad value and indicates that WEST is not financially healthy and even has some risk of bankruptcy.
WEST has a Altman-Z score of 1.17. This is in the lower half of the industry: WEST underperforms 68.54% of its industry peers.
WEST has a Debt/Equity ratio of 0.89. This is a neutral value indicating WEST is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.89, WEST is doing worse than 66.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.17
ROIC/WACCN/A
WACC8.52%
WEST Yearly LT Debt VS Equity VS FCFWEST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

WEST has a Current Ratio of 1.31. This is a normal value and indicates that WEST is financially healthy and should not expect problems in meeting its short term obligations.
WEST has a Current ratio (1.31) which is in line with its industry peers.
A Quick Ratio of 0.68 indicates that WEST may have some problems paying its short term obligations.
WEST has a Quick ratio of 0.68. This is in the lower half of the industry: WEST underperforms 65.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.68
WEST Yearly Current Assets VS Current LiabilitesWEST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

WEST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.91%.
EPS 1Y (TTM)-70.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%34.78%

3.2 Future

The Earnings Per Share is expected to grow by 33.91% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 17.77% on average over the next years. This is quite good.
EPS Next Y18.63%
EPS Next 2Y44.63%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue Next Year26.58%
Revenue Next 2Y17.9%
Revenue Next 3Y17.77%
Revenue Next 5YN/A

3.3 Evolution

WEST Yearly Revenue VS EstimatesWEST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 500M 1B
WEST Yearly EPS VS EstimatesWEST Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WEST. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 64.46, the valuation of WEST can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WEST is on the same level as its industry peers.
WEST's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.69.
Industry RankSector Rank
PE N/A
Fwd PE 64.46
WEST Price Earnings VS Forward Price EarningsWEST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, WEST is valued a bit more expensive than 64.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 30.24
WEST Per share dataWEST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as WEST's earnings are expected to grow with 33.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.63%
EPS Next 3Y33.91%

More info and screens

0

5. Dividend

5.1 Amount

WEST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WESTROCK COFFEE CO

NASDAQ:WEST (9/5/2025, 8:00:02 PM)

After market: 5.15 -0.11 (-2.09%)

5.26

-0.16 (-2.95%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners32.96%
Inst Owner Change-4.17%
Ins Owners6.1%
Ins Owner Change1.11%
Market Cap498.17M
Analysts83.64
Price Target11.02 (109.51%)
Short Float %14.73%
Short Ratio11.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3070.57%
Min EPS beat(2)-6671.48%
Max EPS beat(2)530.34%
EPS beat(4)1
Avg EPS beat(4)-2146.95%
Min EPS beat(4)-6671.48%
Max EPS beat(4)530.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.65%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-6.76%
Revenue beat(4)0
Avg Revenue beat(4)-7.83%
Min Revenue beat(4)-8.54%
Max Revenue beat(4)-6.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.89%
PT rev (3m)3.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 64.46
P/S 0.47
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB 3.35
EV/EBITDA 30.24
EPS(TTM)-0.94
EYN/A
EPS(NY)0.08
Fwd EY1.55%
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS11.3
BVpS4.1
TBVpS1.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.27%
FCFM N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 15.65
Cap/Depr 619.86%
Cap/Sales 15.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.68
Altman-Z 1.17
F-Score2
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)327.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15%
EPS Next Y18.63%
EPS Next 2Y44.63%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%34.78%
Revenue Next Year26.58%
Revenue Next 2Y17.9%
Revenue Next 3Y17.77%
Revenue Next 5YN/A
EBIT growth 1Y-133.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1139.04%
EBIT Next 3Y219.97%
EBIT Next 5Y148.98%
FCF growth 1Y-90.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.13%
OCF growth 3YN/A
OCF growth 5YN/A